Abstract
In modulated electrohyperthermia (mEHT) the enrichment of electric field and the concomitant heat can selectively induce cell death in malignant tumors as a result of elevated glycolysis, lactate production (Warburg effect), and reduced electric impedance in cancer compared to normal tissues. Earlier, we showed in HT29 colorectal cancer xenografts that the mEHT-provoked programmed cell death was dominantly caspase independent and driven by apoptosis inducing factor activation. Using this model here, we studied the mEHT-related cell stress 0-, 1-, 4-, 8-, 14-, 24-, 48-, 72-, 120-, 168- and 216-h post-treatment by focusing on damage-associated molecular pattern (DAMP) signals. Significant cell death response upon mEHT treatment was accompanied by the early upregulation (4-h post-treatment) of heat shock protein (Hsp70 and Hsp90) mRNA levels. In situ, the treatment resulted in spatiotemporal occurrence of a DAMP protein signal sequence featured by the significant cytoplasmic to cell membrane translocation of calreticulin at 4 h, Hsp70 between 14 and 24 h and Hsp90 between 24- and 216-h post-treatment. The release of high-mobility group box1 protein (HMGB1) from tumor cell nuclei from 24-h post-treatment and its clearance from tumor cells by 48 h was also detected. Our results suggest that mEHT treatment can induce a DAMP-related signal sequence in colorectal cancer xenografts that may be relevant for promoting immunological cell death response, which need to be further tested in immune-competent animals.
Similar content being viewed by others
References
Andocs G, Renner H, Balogh L, Fonyad L, Jakab C, Szasz A (2009a) Strong synergy of heat and modulated electromagnetic field in tumor cell killing. Strahlenther Onkol Organ Dtsch Rontgengesellschaft 185:120–126. doi:10.1007/s00066-009-1903-1
Andocs G, Szasz O, Szasz A (2009b) Oncothermia treatment of cancer: from the laboratory to clinic. Electromagn Biol Med 28:148–165. doi:10.1080/15368370902724633
Balogh G et al (2013) Key role of lipids in heat stress management. FEBS Lett 587:1970–1980. doi:10.1016/j.febslet.2013.05.016
Blad B, Baldetorp B (1996) Impedance spectra of tumour tissue in comparison with normal tissue. A possible clinical application for electrical impedance tomography. Physiol Meas 17:A105–A115. doi:10.1088/0967-3334/17/4a/015
Blad B, Wendel P, Jonsson M, Lindstrom K (1999) An electrical impedance index to distinguish between normal and cancerous tissues. J Med Eng Technol 23:57–62. doi:10.1080/030919099294294
Blank M, Goodman R (2009) Electromagnetic fields stress living cells. Pathophysiol Off J Int Soc Pathophysiol/ISP 16:71–78. doi:10.1016/j.pathophys.2009.01.006
Brazma A et al (2001) Minimum information about a microarray experiment (MIAME)—toward standards for microarray data. Nat Genet 29:365–371
Calderwood SK, Mambula SS, Gray PJ Jr (2007) Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci 1113:28–39. doi:10.1196/annals.1391.019
Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6:535–545. doi:10.1038/nrc1894
D’Eliseo D, Manzi L, Velotti F (2013) Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells. Cell Stress Chaperones. doi:10.1007/s12192-013-0422-2
Feyerabend T, Wiedemann GJ, Jager B, Vesely H, Mahlmann B, Richter E (2001) Local hyperthermia, radiation, and chemotherapy in recurrent breast cancer is feasible and effective except for inflammatory disease. Int J Radiat Oncol Biol Phys 49:1317–1325
Fiorentini G, Szasz A (2006) Hyperthermia today: electric energy, a new opportunity in cancer treatment. J Cancer Res Ther 2:41–46
Fiorentini G, Giovanis P, Rossi S, Dentico P, Paola R, Turrisi G, Bernardeschi P (2006) A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia. In vivo (Athens, Greece) 20:721–724
Frey B et al (2012) Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperther Off J Eur Soc Hyperther Oncol N Am Hyperther Group 28:528–542. doi:10.3109/02656736.2012.677933
Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, Agostinis P (2010) Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta 1805:53–71. doi:10.1016/j.bbcan.2009.08.003
Garg AD, Krysko DV, Vandenabeele P, Agostinis P (2012) Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother CII 61:215–221
Garg AD, Martin S, Golab J, Agostinis P (2013) Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death Differ. doi:10.1038/cdd.2013.48
Gehrmann M, Radons J, Molls M, Multhoff G (2008) The therapeutic implications of clinically applied modifiers of heat shock protein 70 (Hsp70) expression by tumor cells. Cell Stress Chaperones 13:1–10. doi:10.1007/s12192-007-0006-0
Guo ZS, Liu Z, Bartlett DL, Tang D, Lotze MT (2013) Life after death: targeting high mobility group box 1 in emergent cancer therapies. Am J Cancer Res 3:1–20
Hager ED, Dziambor H, Hohmann D, Gallenbeck D, Stephan M, Popa C (1999) Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer. Anticancer Res 19:3403–3408
Horvath I, Vigh L (2010) Cell biology: stability in times of stress. Nature 463:436–438. doi:10.1038/463436a
Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Zitvogel L, Kroemer G (2009) Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis Int J Program Cell Death 14:364–375. doi:10.1007/s10495-008-0303-9
Kepp O et al (2011) Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev 30:61–69. doi:10.1007/s10555-011-9273-4
Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51–72. doi:10.1146/annurev-immunol-032712-100008
Krysko O, Love Aaes T, Bachert C, Vandenabeele P, Krysko DV (2013) Many faces of DAMPs in cancer therapy. Cell Death Dis 4:e631. doi:10.1038/cddis.2013.156
Ladoire S et al (2013) Cell-death-associated molecular patterns as determinants of cancer immunogenicity. Antioxid Redox Signal. doi:10.1089/ars.2012.5133
Mace TA, Zhong L, Kokolus KM, Repasky EA (2012) Effector CD8+ T cell IFN-gamma production and cytotoxicity are enhanced by mild hyperthermia. Int J Hyperther Off J Eur Soc Hyperther Oncol N Am Hyperther Group 28:9–18. doi:10.3109/02656736.2011.616182
Mantel F et al (2010) Combination of ionising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells. Strahlenther Onkol Organ Dtsch Rontgengesellschaft 186:587–599. doi:10.1007/s00066-010-2154-x
Martins I et al (2012) Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy 8:413–415. doi:10.4161/auto.19009
Meggyeshazi N et al (2014) DNA fragmentation and caspase-independent programmed cell death by modulated electrohyperthermia. Strahlenther Onkol Organ Dtsch Rontgengesellschaft. doi:10.1007/s00066-014-0617-1
Menger L et al (2012) Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med 4:143ra199. doi:10.1126/scitranslmed.3003807
Mroz P, Hashmi JT, Huang YY, Lange N, Hamblin MR (2011) Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol 7:75–91. doi:10.1586/eci.10.81
Multhoff G, Hightower LE (2011) Distinguishing integral and receptor-bound heat shock protein 70 (Hsp70) on the cell surface by Hsp70-specific antibodies. Cell Stress Chaperones 16:251–255. doi:10.1007/s12192-010-0247-1
Multhoff G, Gaipl US, Niedermann G (2012) The role of radiotherapy in the induction of antitumor immune responses. Strahlenther Onkol Organ Dtsch Rontgengesellschaft 188(Suppl 3):312–315. doi:10.1007/s00066-012-0206-0
Obeid M et al (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13:54–61. doi:10.1038/nm1523
Pfister K et al (2007) Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis. Cancer 110:926–935
Robert J (2003) Evolution of heat shock protein and immunity. Dev Comp Immunol 27:449–464. doi:10.1016/S0145-305X(02)00160-X
Sachamitr P, Fairchild PJ (2012) Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy. Expert Rev Clin Immunol 8:547–555. doi:10.1586/eci.12.45
Scheffer SR et al (2003) Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer 103:205–211. doi:10.1002/ijc.10777
Schildkopf P et al (2010) Application of hyperthermia in addition to ionizing irradiation fosters necrotic cell death and HMGB1 release of colorectal tumor cells. Biochem Biophys Res Commun 391:1014–1020
Tesniere A et al (2010) Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 29:482–491. doi:10.1038/onc.2009.356
Ullrich E, Bonmort M, Mignot G, Kroemer G, Zitvogel L (2008) Tumor stress, cell death and the ensuing immune response. Cell Death Differ 15:21–28
Zou Y, Guo Z (2003) A review of electrical impedance techniques for breast cancer detection. Med Eng Phys 25:79–90. doi:10.1016/s1350-4533(02)00194-7
Acknowledgments
The authors are utterly grateful to Edith Parsch, Renata Papp, and Sandor Kiss for their technical assistance. This work was supported by TET_10-1-2011-0914 grant in Hungary.
Author information
Authors and Affiliations
Corresponding author
Additional information
Gabor Andocs and Nora Meggyeshazi equally contributed to this work.
Rights and permissions
About this article
Cite this article
Andocs, G., Meggyeshazi, N., Balogh, L. et al. Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia. Cell Stress and Chaperones 20, 37–46 (2015). https://doi.org/10.1007/s12192-014-0523-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12192-014-0523-6